- Grants since 2016
- 484
- Awarded, last 5 years (where amounts are published)
- 57M
- Funded works, last 5 years
- 437
- Funded works, all time
- 2 006
Grants
2020–2021 · award
Expanded Access to the FUS-ASO, Jacifusen for the Treatment of Mutant FUS-Associated ALS
Neil Shneider
2020–2022 · award
Establishing the Natural History of Upper Motor Neurondominant ALS and PLS
Hiroshi Mitsumoto
2020–2022 · award
Eye gaze-based technology using Apple TrueDepth camera to enable communication for ALS patients
Fusheng Wang
2020–2022 · award
Targeting soITNF-dependent inflammation in ALS with XPro1595
Christopher Barnum
2020–2021 · award
Developing Chemically Induced Senescence to Model ALS Pathogenesis Using iPSCs
Su Chun Zhang
2020–2022 · award
Respiratory Health Management in Amytrophic Lateral Sclerosis through Telemonitoring and Nurse Health Coaching
Zachary Simmons
2020 · award
Natural History Pilot Project-Providence
Nicholas Olney
2020–2022 · award
The ALS Association Clinical Trial Support Program-MGH
Merit Cudkowicz
2020–2022 · award
Eye Gaze Controlled Neck Brace for ALS Patients with Head Drop
Sunil Agrawal
2020–2021 · award
Prognostic Value of miRNAs in biofluids from ALS patients
Eran Hornstein
2020 · award
Natural History Pilot Project-NEMO
Christian Lunetta
2019–2020 · award
SEA Award for 2019
Aaron Gitler
2019–2023 · award
Identifying NK Cells as a Therapeutic Targets in ALS
Benjamin Murdock
2019–2022 · award
ALS Patient Progression Tracking Mobile App vs Clinical Data Collection
Chris Tyler
2019–2021 · award
CK1e-mediated TDP-43 phosphorylation
John Ravits
2019–2021 · award
Synergistic dual target approach to ALS therapy: simultaneous activation of two complementary targets, neuronal Kv7.2/3 channels and glial TSPO
Brigitte Van Zundert
2019–2022 · award
Establishing a Central Repository for Whole Genome Sequencing of ALS Patients
John Landers
2019–2021 · award
Antisense oligonucleotide therapy in ALS by restoring expression of stathmin-2
Don Cleveland
2019–2023 · award
Microbiome in Progression of ALS
Vicki Hertzberg
2019–2020 · award
Development of ebselen and its derivatives as a potential drug for ALS
Samar Hasnain
2019–2020 · award
Maintain the SOD1 breeding colony in 2019
Taconic Biosciences · Taconic Biosciences, Inc.
2019–2021 · award
Understanding repeat RNA transport and RAN translation in C9ORF72-ALS/FTD
Zhe Zhang
2019–2020 · award
Degradation of C9orf72 Repeat RNAs using RNA-targeting CRISPR effectors
Thomas Gaj
2019–2021 · award
An unbiased approach to identify network disruptions and remodeling in the motor system of ALS rodents
Christi Kolarcik
2019–2021 · award
Exploring the disease-modifying effects of EH301 in mouse models of ALS
Giovanni Manfredi
2019–2020 · award
Actin and Micotubule Cross talk Mediated by Profilin-1, TDP-43, and Liquid-droplets in ALS
Jessica Henty-Ridilla
2019–2022 · award
NEALS Infrastructure Support
Timothy Miller
2019–2020 · award
Role of the extracellular matrix in C9-ALS
Jeffrey Frost
2019–2020 · award
Blood levels of Alpha-Linolenic acid and ALS progression
Alberto Ascherio
2019–2021 · award
The impact of nuedexta on bulbar physiology and function in ALS
Emily Plowman
2019–2020 · award
Reducing leg muscle denervation in SOD1 G93A mice with an agonist antibody to MuSK
Steven Burden
2019–2021 · award
Caregivers in South Africa: Building community based ALS/MND caregiver interventions in South Africa
Melinda Kavanaugh
2019–2021 · award
The E-health Application To Modify Oral Engery intake and Measure Outcomes Remotely in ALS Clinical Trial (EAT MORE2)
Anne-Marie Wills
2019–2021 · award
Development of novel PIKfyve inhibitors for C9orf72ALS
Justin Ichida
2019–2020 · award
Modification to 20-LGCA-367, NeuroBank as an Accelerated Clinical Research Environment: Development, CORE Services to ALS Research Community
Alexander Sherman
2019–2022 · award
ALS Gene and Environment Interactions
Stephen Goutman
2019–2021 · award
Support of Early Phase Clinical Trials with a User Interface that Returns ALS Disease Progression Predictions
David Ennist
2019–2021 · award
The cell autonomous and non-cell autonomous role of TBK1 in disease progression in a mouse model of ALS
Valeria Gerbino
2019–2021 · award
C9ORF72: Endobody vaccine for the treatment of C9 ALS/FTD
Lisa Romano
2019–2023 · award
Antagonizing neurotoxic phase transitions of TDP-43 and FUS with small RNA therapeutics
James Shorter